68Ga-FAPI PET的陷阱与常见表现:图示分析
81.3%患者存在非肿瘤特异性摄取,最常见为退行性病变(51.6%)和头颈部表现(45.1%);子宫摄取见于多数女性(66.7%)且与年龄负相关。
要点
- 68Ga-FAPI PET/CT中非肿瘤特异性摄取常见,81.3%患者至少一处。
- 退行性病变(51.6%)与头颈部表现(45.1%)为最常见陷阱部位。
- 多数表现注射后10至60分钟摄取值无差异,唾液腺除外。
核心结论
- 68Ga-FAPI PET/CT的陷阱包括退行性病变、肌肉、头颈部、瘢痕、乳腺及子宫的非肿瘤特异性摄取。
主要发现
- 81.3%患者存在非肿瘤特异性摄取,退行性病变最常见(51.6%),平均SUVmax为7.7 ± 2.9。
- 头颈部表现见于45.1%患者。
- 除唾液腺外,多数表现注射后10与60分钟摄取值无差异。
- 子宫摄取见于66.7%女性,平均SUVmax为12.2 ± 7.3,且与年龄负相关(SUVmax r = -0.6,P < 0.01;SUVpeak r = -0.57,P < 0.01;SUVmean r = -0.58,P < 0.01)。
关键数值与推荐
- 陷阱与常见表现定义为高于背景水平的局灶或局限性摄取,归为退行性、肌肉、瘢痕/伤口愈合、子宫、乳腺及头颈部表现。
临床怎么用
- 在开展68Ga-FAPI PET/CT的中心,阅片时应识别上述非肿瘤特异性摄取部位以避免误判。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fibroblast activation protein inhibitor (FAPI) PET/CT is a new tool in the diagnostic workup of cancer. With a growing volume of applications, pitfalls and common findings need to be considered for 68Ga-FAPI PET/CT image interpretation. The aim of this study was to summarize common findings and report pitfalls in 68Ga-FAPI PET/CT. Methods: Ninety-one patients underwent whole-body PET/CT with either FAPI-04 (n = 25) or FAPI-46 (n = 66). Findings were rated in a consensus session of 2 experienced readers. Pitfalls and common findings were defined as focal or localized uptake above the background level and categorized as unspecific or nonmalignant and grouped into degenerative, muscular, scarring/wound-healing, uterine, mammary gland, and head-and-neck findings. The frequency of findings was reported on a per-patient and per-group basis, and SUVmax, SUVmean, and SUVpeak were measured. Results: Non-tumor-specific uptake was found in 81.3% of patients. The most frequent finding was uptake in degenerative lesions (51.6%), with a mean SUVmax of 7.7 ± 2.9, and head-and-neck findings (45.1%). Except for the salivary glands, the uptake values did not differ between 10 and 60 min after injection in most findings. Uterine uptake was found in most women (66.7%), with a mean SUVmax of 12.2 ± 7.3, and uptake correlated negatively with age (SUVmax, r = -0.6, P < 0.01; SUVpeak, r = -0.57, P < 0.01; SUVmean, r = -0.58, P < 0.01). Conclusion: Pitfalls include non-tumor-specific 68Ga-FAPI uptake in degenerative lesions, muscle, the head and neck, scarring, the mammary glands, or the uterus. Here, we summarize the findings to help readers avoid common mistakes at centers introducing 68Ga-FAPI PET/CT.
引用
- Kessler L, Ferdinandus J, Hirmas N, et al. Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis. J Nucl Med. 2021. PMID: 34620730. doi:10.2967/jnumed.121.262808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。